Publicly traded biotech companies accounted for only 1.1 percent of the 1.24 million square feet Alexandria Real Estate Equities leased in the third...
ByThe RegistryNovember 6, 2026Seattle biologics developer Lumen Bioscience landed the largest notable life sciences lease in the Seattle market in the third quarter, a 39,000-square-foot deal...
ByThe RegistryNovember 4, 2026Alexandria Real Estate Equities' third-quarter results show its Seattle strategy of converting surplus lab sites to housing and courting advanced technology tenants still...
ByThe RegistryNovember 3, 2026Seattle life science companies raised only $395.9 million through the third quarter, on pace for the weakest year since at least 2022, as...
ByThe RegistryOctober 20, 2026 
Signup for news and special announcements!
You have successfully joined our subscriber list.